2025 $30 Call)
Search documents
Is the Options Market Predicting a Spike in United Parks & Resorts (PRKS) Stock?
ZACKS· 2025-05-30 16:22
Group 1 - The stock of United Parks & Resorts Inc. (PRKS) is experiencing significant attention due to high implied volatility in the options market, particularly for the June 20, 2025 $30 Call option [1] - Implied volatility indicates the market's expectation of future price movement, suggesting that investors anticipate a substantial price change or an upcoming event that could trigger a rally or sell-off [2] - United Parks & Resorts holds a Zacks Rank 3 (Hold) in the Leisure and Recreation Services industry, which is in the top 37% of the Zacks Industry Rank [3] Group 2 - Over the past 60 days, there have been mixed changes in earnings estimates for United Parks & Resorts, with two analysts increasing and two decreasing their estimates, resulting in a slight decline in the Zacks Consensus Estimate from $1.76 to $1.74 per share [3] - The high implied volatility may indicate a potential trading opportunity, as options traders often seek to sell premium on options with high implied volatility, aiming for the underlying stock to not move as much as expected at expiration [4]
Is the Options Market Predicting a Spike in Supernus Pharmaceuticals (SUPN) Stock?
ZACKS· 2025-05-14 19:31
Group 1 - Supernus Pharmaceuticals, Inc. (SUPN) is experiencing significant activity in the options market, particularly with the June 20, 2025 $30 Call showing high implied volatility, indicating potential for a major price movement [1] - Implied volatility reflects market expectations for future stock movement, suggesting that investors anticipate a significant event that could lead to a substantial price change [2] - Supernus Pharmaceuticals holds a Zacks Rank 3 (Hold) in the Medical - Generic Drugs industry, which is in the bottom 16% of the Zacks Industry Rank, indicating a relatively weak position within the sector [3] Group 2 - Over the past 60 days, one analyst has raised earnings estimates for Supernus Pharmaceuticals for the current quarter from 46 cents per share to 48 cents, while no analysts have lowered their estimates, reflecting a slight positive sentiment [3] - The high implied volatility may present trading opportunities, as options traders often seek to sell premium on options with elevated implied volatility, aiming to benefit from time decay if the stock does not move as expected [4]